Software to compute and conduct sequential Bayesian phase I or II dose-ranging clinical trials with stopping rules

Author： Zohar S.   Latouche A.   Taconnet M.   Chevret S.  

Publisher： Elsevier

ISSN： 0169-2607

Source： Computer Methods and Programs in Biomedicine, Vol.72, Iss.2, 2003-10, pp. : 117-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase I/II trials of autologous peripheral blood stem cell transplantation in autoimmune diseases resistant to conventional therapy: preliminary results from the Spanish experience

By Espigado I.   Marn-Niebla A.   Rovira M.   Julia A.   Rodrguez J.M.   Altes A.   Arranz R.   Bargay J.   Diez J.L.   Fores R.   Morales A.   Graus F.   Messague I.   Hernandez J.C.   Parody R.   Richard C.   Ferra C.   Garca A.   Carreras E.  

Transplantation Proceedings, Vol. 35, Iss. 2, 2003-03 ,pp. : 742-743

Elsevier

Access to resources Recommend Favorite

Development of Tumor B-cell Lymphocyte Hybridoma (TBH) Autovaccination. Results of a Phase I-II Clinical Trial

By Moviglia G.A.  

Transfusion and Apheresis Science, Vol. 17, Iss. 4, 1996-12 ,pp. : 643-649

Elsevier

Access to resources Recommend Favorite

Development of Tumor B-cell Lymphocyte Hybridoma (TBH) Autovaccination. Results of a Phase I-II Clinical Trial

By Moviglia G.A.  

Transfusion Science, Vol. 17, Iss. 4, 1996-12 ,pp. : 643-649

Elsevier

Access to resources Recommend Favorite

Clinical Pharmacogenomics and Transcriptional Profiling in Early Phase Oncology Clinical Trials

By  

Current Molecular Medicine, Vol. 5, Iss. 1, 2005-02 ,pp. : 83-102

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical trials of antibody therapy

By Glennie M.J.   Johnson P.W.M.  

Immunology Today, Vol. 21, Iss. 8, 2000-08 ,pp. : 403-410

Elsevier

Access to resources Recommend Favorite